Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 2,166 | 43,635 | 729 | 729 | 729 |
| Cost of Goods | 3,951 | 2,961 | 0 | N/A | N/A |
| Gross Profit | -1,785 | 40,674 | 729 | 729 | 729 |
| Operating Expenses | 9,505 | 10,566 | 10,332 | 11,629 | 7,122 |
| Operating Income | -10,339 | 31,069 | -9,603 | -10,900 | -6,393 |
| Interest Expense | 461 | 372 | 222 | 280 | 333 |
| Other Income | -1,612 | -31,496 | -10,887 | 907 | -195 |
| Pre-tax Income | -12,412 | -799 | -20,712 | -10,273 | -6,921 |
| Net Income Continuous | -12,412 | -799 | -20,712 | -10,273 | -6,921 |
| Net Income | $-12,412 | $-799 | $-20,712 | $-10,273 | $-6,921 |
| EPS Basic Total Ops | -0.72 | -0.05 | -1.31 | -0.72 | -0.52 |
| EPS Basic Continuous Ops | -0.72 | -0.05 | -1.31 | -0.71 | -0.52 |
| EPS Diluted Total Ops | -0.72 | -0.05 | -1.31 | -0.72 | -0.52 |
| EPS Diluted Continuous Ops | -0.72 | -0.05 | -1.31 | -0.71 | -0.52 |
| EBITDA(a) | $-8,913 | $31,984 | $-8,673 | $-9,934 | $-5,391 |